agilon health (NYSE:AGL - Get Free Report) had its price target hoisted by equities research analysts at Stifel Nicolaus from $2.00 to $3.00 in a research report issued on Wednesday,Benzinga reports. The brokerage presently has a "hold" rating on the stock. Stifel Nicolaus' target price indicates a potential downside of 3.85% from the stock's current price.
Other analysts have also recently issued reports about the stock. Royal Bank of Canada reissued an "outperform" rating and set a $3.00 target price on shares of agilon health in a report on Tuesday, November 19th. Sanford C. Bernstein lifted their target price on agilon health from $2.50 to $3.15 and gave the company a "market perform" rating in a research note on Wednesday, January 15th. Barclays decreased their target price on agilon health from $5.00 to $2.00 and set an "underweight" rating for the company in a research note on Monday, November 11th. TD Cowen dropped their target price on agilon health from $6.00 to $2.00 and set a "hold" rating on the stock in a research report on Monday, November 11th. Finally, Macquarie began coverage on agilon health in a research report on Monday, December 16th. They issued a "neutral" rating and a $3.00 target price on the stock. Two analysts have rated the stock with a sell rating, thirteen have assigned a hold rating and two have assigned a buy rating to the company. According to MarketBeat, agilon health presently has a consensus rating of "Hold" and an average price target of $3.95.
Get Our Latest Stock Analysis on AGL
agilon health Stock Performance
Shares of AGL traded down $0.23 during mid-day trading on Wednesday, hitting $3.12. The stock had a trading volume of 6,347,607 shares, compared to its average volume of 5,615,979. The company has a market cap of $1.29 billion, a PE ratio of -3.32 and a beta of 0.67. agilon health has a fifty-two week low of $1.50 and a fifty-two week high of $7.73. The company's fifty day simple moving average is $2.96 and its two-hundred day simple moving average is $3.03. The company has a quick ratio of 1.29, a current ratio of 1.29 and a debt-to-equity ratio of 0.06.
Insider Activity at agilon health
In related news, Director John William Wulf bought 45,000 shares of the firm's stock in a transaction that occurred on Thursday, December 5th. The shares were acquired at an average cost of $2.18 per share, for a total transaction of $98,100.00. Following the acquisition, the director now directly owns 206,133 shares of the company's stock, valued at $449,369.94. The trade was a 27.93 % increase in their position. The transaction was disclosed in a document filed with the SEC, which is available through this link. Also, Director Karen Mcloughlin acquired 25,000 shares of the business's stock in a transaction on Friday, December 13th. The shares were bought at an average price of $2.20 per share, for a total transaction of $55,000.00. Following the acquisition, the director now owns 73,166 shares in the company, valued at approximately $160,965.20. This trade represents a 51.90 % increase in their position. The disclosure for this purchase can be found here. Insiders have purchased 77,500 shares of company stock worth $169,600 over the last quarter. 3.20% of the stock is currently owned by company insiders.
Institutional Investors Weigh In On agilon health
A number of institutional investors have recently bought and sold shares of AGL. Vanguard Group Inc. increased its holdings in agilon health by 0.9% in the fourth quarter. Vanguard Group Inc. now owns 31,112,407 shares of the company's stock worth $59,114,000 after buying an additional 272,787 shares during the last quarter. Capital International Investors lifted its holdings in shares of agilon health by 72.0% during the fourth quarter. Capital International Investors now owns 22,331,873 shares of the company's stock worth $42,431,000 after buying an additional 9,346,295 shares during the last quarter. State Street Corp grew its position in agilon health by 3.0% in the 3rd quarter. State Street Corp now owns 7,449,706 shares of the company's stock worth $29,277,000 after purchasing an additional 215,733 shares during the last quarter. Millennium Management LLC raised its holdings in agilon health by 187.8% in the 4th quarter. Millennium Management LLC now owns 7,212,525 shares of the company's stock valued at $13,704,000 after acquiring an additional 4,706,357 shares in the last quarter. Finally, Geode Capital Management LLC raised its holdings in agilon health by 0.5% in the 4th quarter. Geode Capital Management LLC now owns 6,928,724 shares of the company's stock valued at $13,168,000 after acquiring an additional 35,207 shares in the last quarter.
agilon health Company Profile
(
Get Free Report)
agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month. The company was formerly known as Agilon Health Topco, Inc and changed its name to agilon health, inc.
Featured Articles

Before you consider agilon health, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and agilon health wasn't on the list.
While agilon health currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Looking to profit from the electric vehicle mega-trend? Enter your email address and we'll send you our list of which EV stocks show the most long-term potential.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.